Command Palette

Search for a command to run...

Clinical Trials · NCT04624672

Treatment of GLP-1 for Diabetic Bariatric Patients

TerminatedPhase 4Semaglutide (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Geisinger Clinic
Enrollment
3
Start date
Aug 2021
Locations
1 site, United States
Primary endpoint
RATE OF PARTIAL REMISSION OF DIABETES
View Semaglutide compound reference